Prospective Observational Study to Describe Characteristics and Management of Postmenopausal Women With Osteoporosis Treated With Prolia® in France and Its Use in Routine Clinical Practice
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 08 Dec 2017
At a glance
- Drugs Denosumab (Primary)
- Indications Postmenopausal osteoporosis
- Focus Therapeutic Use
- Acronyms PILOTE
- Sponsors Amgen
- 17 Oct 2017 Planned primary completion date changed from 1 Mar 2017 to 11 Dec 2017.
- 14 Feb 2017 Planned End Date changed from 1 Sep 2018 to 1 Jul 2018.
- 08 Dec 2016 Status changed from recruiting to active, no longer recruiting.